Cellular structure of bone (MS system) Flashcards
1
Q
Bone types and classifications
A
Anatomical bones:
- flat, long, short/cuboid, irregular, sesamoid
Macroscopic structure:
- trabecular / cancellous / spongy
- cortical / compact
Microscopic structure:
- woven bone (immature)
- lamellar bone (mature)
2
Q
Cortical vs Trabecular
A
Cortical:
- long bones
- 80% of skeleton
- appendicular
- 80-90% calcified
- mainly structural, mechanical and protective
Trabecular:
- vertebrae and pelvis
- 20% of skeleton
- axial
- 15-25% calcified
- mainly metabolic
- large surface area
3
Q
Bone development
A
Bones develop throughout growth and into adulthood:
- growth plate fusion and ossification completes development
- clavicles growth plates fuse at around 20 years
Intramembranous ossification:
- direct differentiation of osteoblasts from connective tissue
- flat bones
Endochondral ossification:
- bones form form a cartilage model
- long bones
- growth plate allows rapid growth
4
Q
Specialised bone cells
A
- the skeleton is not a fixed or stagnant organ
- it is dynamically regulated to maintain health
- small portions of bone are constantly being removed and replaced
- your whole skeleton has been replaced after 7 years
- this is done by the specialised bone cells via the bone remodelling cycle
Types of cells:
Osteocytes - mechanosensory network embedded in mature bone
Osteoclasts - multinuclear cells that reabsorb and remove bone
Osteoblasts - produce osteoid to form new bone
5
Q
Osteoclasts
A
- giant multinuclear cells formed from the fusion of macrophages
- seal off a portion of bone beneath them
- they secrete acids and enzymes to resorb and sealed off bone
6
Q
Osteoblasts
A
- form new bone
- secretes osteoid (organic compound of new bone)
- osteoid is mineralised over time to become mature bone
- some are embedded in new bone and differentiate into osteocytes
7
Q
Control of bone remodelling
A
Endocrine:
- oestrogen
- thyroid hormone
- PTH
Paracrine:
- RANKL
- Wnt signalling
8
Q
Osteoclast differentiation and RANKL
A
- RANK receptor - activation required for osteoclast differentiation and survival
- RANK ligand - produced by osteocytes and osteoblasts
- OPG (osteoprotegerin) - decoy receptor for RANKL also produced by osteocytes and osteblasts
9
Q
Wnt signalling and bone formation
A
- highly complex pathway involved in many different organ systems
- stimulates osteoblast differentiation
- inhibited by Sclerostin and Dkk-1
10
Q
Bone disorder - Osteopetrosis
A
- LRP5 activating mutations
- van Buchem’s and SOST
- defined as having a bone mass greater than 2.5 SD below average peak bone mass
- estimated that it will effect 1:2 women and 1:5 men
- causes 500,000 low impact bone fractures every year in UK
- can be primary (menopause, ageing) or secondary (drugs, disease, lifestyle)